Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Machine learning and burden analyses highlight novel genes in Parkinson’s Disease

Sitki Cem Parlar, Eric Yu, Sajanth Kanagasingam, Meredith Zhang, Lang Liu, Morvarid Ghamgosar Shahkhali, Cloe Chantereault, Nathan Karpilovsky, Donovan Worrall, Rhalena A Thomas, Konstantin Senkevich, Edward A Fon, Ziv Gan-Or
doi: https://doi.org/10.64898/2026.01.22.26344646
Sitki Cem Parlar
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Yu
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sajanth Kanagasingam
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meredith Zhang
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lang Liu
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morvarid Ghamgosar Shahkhali
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cloe Chantereault
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Karpilovsky
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
5Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donovan Worrall
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
5Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rhalena A Thomas
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
5Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin Senkevich
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
6Department of Specialized Medicine, Division of Medical Genetics, McGill University Health Centre, Montreal, Québec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward A Fon
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
5Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montréal, Québec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ziv.gan-or{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Genome-wide association studies (GWAS) have identified numerous risk loci for Parkinson’s disease, yet identifying causal genes and mechanisms remains challenging due to non-coding associations and complex linkage disequilibrium.

Methods We prioritized genes within 147 GWAS loci using an XGBoost machine-learning model trained on 285 multi-omic features, including brain-specific eQTLs and single-cell expression. Prioritized candidates underwent gene- and domain-level rare variant burden analysis via optimal sequenced kernel association test (SKAT-O) across the Accelerating Medicines Partnership for Parkinson’s Disease and UK Biobank cohorts (N case = 6,435, N proxy = 13,889, N control = 343,160).

Findings The model prioritized 406 genes with 48 features contributing to the prioritization. Meta-analysis of rare variants at the gene and domain levels replicated established associations (GBA1, LRRK2) and identified six novel potential risk genes ANKRD27 driven by p.Arg21Cys, UBXN2A, FAM171A1, ERCC8, BNC2, and ADNP. Domain-level analysis uniquely uncovered a significant association in the zinc-finger domain of ADNP, which was masked in gene-level tests. Additionally, at cohort-level, one novel gene was nominated: LRRC45 driven by p.Met607ArgfsTer57.

Interpretation Integrating machine-learning prioritization with gene- and domain-level burden testing identified novel genes potentially involved in Parkinson’s disease, with further validation needed to elucidate causality and mechanisms.

Funding This study was supported by grants from the Galen and Hilary Weston Foundation, the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), the Canada First Research Excellence Fund (CFREF). Lastly, the study received contributions from the G-Can (GBA1-Canada) Initiative. G-Can is supported by The Hilary and Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier. S.C.P. is supported by a Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship – Doctoral (CGS-D) award. Z.G.-O. holds a Fonds de recherche du Québec - Santé (FRQS) Chercheurs-boursiers award and is a William Dawson Scholar.

Competing Interest Statement

Z. G.-O. received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Neuron23, Handl Therapeutics, UCB, Capsida, Vanqua Bio, Congruence Therapeutics, Ono Therapeutics, Denali, Bial Biotech, Bial, EG427, Takeda, Jazz Pharmaceuticals, Simcere, Guidepoint, Lighthouse, and Deerfield. K.S. received consultancy fees from Acurex.

Funding Statement

This work was supported by grants from the Galen and Hilary Weston Foundation, the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), and the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives (HBHL) initiative. We also acknowledge contributions from the G-Can (GBA1-Canada) Initiative, an open-science collaboration dedicated to GBA1-associated neurodegeneration. G-Can is supported by the Galen and Hilary Weston Foundation, the Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier. S.C.P. is supported by a Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship - Doctoral (CGS-D) award. Z.G.-O. holds a Fonds de recherche du Québec - Santé (FRQS) Chercheurs-boursiers award and is a William Dawson Scholar.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board of McGill University gave ethical approval for this work (IRB Study Number 21-11-023).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The WGS cohort accessed and analysed in this study for the purposes of the burden analysis are accessible (conditional to institutional approval) at: AMP-PD Knowledge Platform (https://www.amp-pd.org) and the UK Biobank Research Analysis Platform. All information directly relevant to the study are included in the text and the supplementary files of this article, except for the full range of analysed variants, which have been made accessible online at the link: https://doi.org/10.5281/zenodo.18285356. All the scripts used in the machine learning prioritization and burden analyses are shared at the GitHub repository link: https://github.com/gan-orlab/ML_and_Burden_PD.

https://doi.org/10.5281/zenodo.18285356

https://github.com/gan-orlab/ML_and_Burden_PD

  • Abbreviations

    AMP-PD
    Accelerating Medicines Partnership for Parkinson’s Disease
    eQTL
    Expression quantitative trait loci
    GWAS
    Genome-wide association studies
    ML
    Machine learning
    PD
    Parkinson’s disease
    SKAT-O
    Optimal sequenced kernel association test
    UKBB
    UK Biobank
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted January 23, 2026.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Machine learning and burden analyses highlight novel genes in Parkinson’s Disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Machine learning and burden analyses highlight novel genes in Parkinson’s Disease
    Sitki Cem Parlar, Eric Yu, Sajanth Kanagasingam, Meredith Zhang, Lang Liu, Morvarid Ghamgosar Shahkhali, Cloe Chantereault, Nathan Karpilovsky, Donovan Worrall, Rhalena A Thomas, Konstantin Senkevich, Edward A Fon, Ziv Gan-Or
    medRxiv 2026.01.22.26344646; doi: https://doi.org/10.64898/2026.01.22.26344646
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Machine learning and burden analyses highlight novel genes in Parkinson’s Disease
    Sitki Cem Parlar, Eric Yu, Sajanth Kanagasingam, Meredith Zhang, Lang Liu, Morvarid Ghamgosar Shahkhali, Cloe Chantereault, Nathan Karpilovsky, Donovan Worrall, Rhalena A Thomas, Konstantin Senkevich, Edward A Fon, Ziv Gan-Or
    medRxiv 2026.01.22.26344646; doi: https://doi.org/10.64898/2026.01.22.26344646

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Genetic and Genomic Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (638)
    • Allergy and Immunology (917)
    • Anesthesia (350)
    • Cardiovascular Medicine (5005)
    • Dentistry and Oral Medicine (496)
    • Dermatology (428)
    • Emergency Medicine (676)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1691)
    • Epidemiology (16263)
    • Forensic Medicine (36)
    • Gastroenterology (1241)
    • Genetic and Genomic Medicine (7278)
    • Geriatric Medicine (751)
    • Health Economics (1093)
    • Health Informatics (5288)
    • Health Policy (1467)
    • Health Systems and Quality Improvement (1832)
    • Hematology (599)
    • HIV/AIDS (1381)
    • Infectious Diseases (except HIV/AIDS) (16490)
    • Intensive Care and Critical Care Medicine (1203)
    • Medical Education (700)
    • Medical Ethics (156)
    • Nephrology (752)
    • Neurology (7596)
    • Nursing (377)
    • Nutrition (1130)
    • Obstetrics and Gynecology (1296)
    • Occupational and Environmental Health (1040)
    • Oncology (3746)
    • Ophthalmology (1093)
    • Orthopedics (409)
    • Otolaryngology (465)
    • Pain Medicine (501)
    • Palliative Medicine (143)
    • Pathology (721)
    • Pediatrics (1858)
    • Pharmacology and Therapeutics (755)
    • Primary Care Research (786)
    • Psychiatry and Clinical Psychology (6130)
    • Public and Global Health (9992)
    • Radiology and Imaging (2530)
    • Rehabilitation Medicine and Physical Therapy (1519)
    • Respiratory Medicine (1269)
    • Rheumatology (661)
    • Sexual and Reproductive Health (804)
    • Sports Medicine (597)
    • Surgery (803)
    • Toxicology (109)
    • Transplantation (319)
    • Urology (308)